# A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose

> **NCT03250182** · PHASE1 · COMPLETED · sponsor: **Pearl Therapeutics, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** PT010

## Key facts

- **NCT ID:** NCT03250182
- **Lead sponsor:** Pearl Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-11
- **Primary completion:** 2017-12-07
- **Final completion:** 2017-12-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03250182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03250182, "A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03250182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*